Traumatic Brain Injury
Pipeline by Development Stage
On Market (3)
Approved therapies currently available
Competitive Landscape
13 companies ranked by most advanced pipeline stage
Trial Timeline
Clinical trial activity over time
Showing 15 of 19 trials with date data
Clinical Trials (19)
Total enrollment: 2,840 patients across 19 trials
Optimized Therapy in Severe Traumatic Brain Injured Patients
Study to Evaluate the Safety, Tolerability, and Efficacy of Armodafinil as Treatment for Patients With Excessive Sleepiness Associated With Mild or Moderate Closed Traumatic Brain Injury
Efficacy and Safety of Rivastigmine in Patients With Traumatic Brain Injury and Cognitive Impairment
IL-1ra Dose-range Study for Moderate-to-severe TBI Patients
Copenhagen Head Injury Ciclosporin (CHIC) Study
Safety and Tolerability of Oxycyte in Patients With Traumatic Brain Injury (TBI)
An Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics Study of JNJ-17299425 in Participants With Traumatic Brain Injury
Study of Oxycyte in Severe Closed Head Injury
Safety and Tolerability of PNT001 in Patients With Acute Traumatic Brain Injury (TBI)
Traumatic Brain Injury Peripheral Nerve Study
Effects of TT301 on Cytokine Levels Post Endotoxin Challenge
Non-invasive Deep Brain Stimulation to Improve Spatial Navigation Abilities in Individuals Following Traumatic Brain Injury
Evaluation of the Abbott i-STAT TBI Biomarker Test
Plasticity of Deep Brain Structures in Mild Cognitive Impairment and Healthy Aging
Clinical Evaluation of the i-STAT TBI Test
Brain Injury Assessment Study at Hennepin County Medical Center
Hormone Deficiency After Brain Injury During Combat
A Pilot Study of NSICU Assessment of Seizure Prophylaxis With Lacosamide
Pituitary Functions After Traumatic Brain Injury (TBI) and/or Subarachnoid Hemorrhage (SAH)